Lamazym Aftercare Study

NCT01908725 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Alpha-Mannosidosis

Interventions

DRUG: Lamazym

Sponsor

Chiesi Farmaceutici S.p.A.